265 related articles for article (PubMed ID: 30238404)
1. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.
Kim NJ; Locke CJ; Park H; Magee C; Bacchetti P; Khalili M
J Gen Intern Med; 2019 Oct; 34(10):2005-2013. PubMed ID: 30238404
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
[TBL] [Abstract][Full Text] [Related]
3. Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
Beck KR; Kim N; Khalili M
Dig Dis Sci; 2016 Dec; 61(12):3602-3608. PubMed ID: 27743164
[TBL] [Abstract][Full Text] [Related]
4. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
Beck KR; Kim NJ; Khalili M
Ann Hepatol; 2018; 17(3):413-418. PubMed ID: 29735789
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
Supanan R; Han WM; Harnpariphan W; Ueaphongsukkit T; Ubolyam S; Sophonphan J; Tangkijvanich P; Thanprasertsuk S; Avihingsanon A;
J Acquir Immune Defic Syndr; 2021 Dec; 88(5):465-469. PubMed ID: 34757974
[TBL] [Abstract][Full Text] [Related]
6. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
[TBL] [Abstract][Full Text] [Related]
7. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection.
Su F; Green PK; Berry K; Ioannou GN
Hepatology; 2017 Feb; 65(2):426-438. PubMed ID: 27775854
[TBL] [Abstract][Full Text] [Related]
8. High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.
Miller LS; Rollin F; Fluker SA; Lundberg KL; Park B; Quairoli K; Niyibizi NK; Spaulding AC
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):84-90. PubMed ID: 27168666
[TBL] [Abstract][Full Text] [Related]
9. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
[TBL] [Abstract][Full Text] [Related]
10. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness.
Khalili M; Powell J; Park HH; Bush D; Naugle J; Ricco M; Magee C; Braimoh G; Zevin B; Fokuo JK; Masson CL
Hepatol Commun; 2022 Jan; 6(1):50-64. PubMed ID: 34628726
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.
Roberson JL; Lagasca AM; Kan VL
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):148-155. PubMed ID: 28974107
[TBL] [Abstract][Full Text] [Related]
12. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
Rodriguez-Torres M; Lawitz E; Yangco B; Jeffers L; Han SH; Thuluvath PJ; Rustgi V; Harrison S; Ghalib R; Vierling JM; Luketic V; Zamor PJ; Ravendhran N; Morgan TR; Pearlman B; O'Brien C; Khallafi H; Pyrsopoulos N; Kong G; McPhee F; Yin PD; Hughes E; Treitel M
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):834-845. PubMed ID: 27740516
[TBL] [Abstract][Full Text] [Related]
13. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
14. Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.
Miller LS; Millman AJ; Lom J; Osinubi A; Ahmed F; Dupont S; Rein D; Vellozzi C; Harris AM
J Viral Hepat; 2020 Jan; 27(1):13-19. PubMed ID: 31505088
[TBL] [Abstract][Full Text] [Related]
15. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
16. Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
Stewart RA; MacDonald BR; Chu TC; Moore JD; Fasanmi EO; Ojha RP
Dig Dis Sci; 2018 Dec; 63(12):3233-3240. PubMed ID: 30014226
[TBL] [Abstract][Full Text] [Related]
17. Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk.
Litwin AH; Smith BD; Drainoni ML; McKee D; Gifford AL; Koppelman E; Christiansen CL; Weinbaum CM; Southern WN
Dig Liver Dis; 2012 Jun; 44(6):497-503. PubMed ID: 22342471
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C care cascade in a large academic healthcare system, 2012 to 2018.
Nakayama J; Hertzberg VS; Ho JC; Simpson RL; Cartwright EJ
Medicine (Baltimore); 2023 Mar; 102(10):e32859. PubMed ID: 36897716
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.
Calleja JL; Crespo J; Rincón D; Ruiz-Antorán B; Fernandez I; Perelló C; Gea F; Lens S; García-Samaniego J; Sacristán B; García-Eliz M; Llerena S; Pascasio JM; Turnes J; Torras X; Morillas RM; Llaneras J; Serra MA; Diago M; Rodriguez CF; Ampuero J; Jorquera F; Simon MA; Arenas J; Navascues CA; Bañares R; Muñoz R; Albillos A; Mariño Z;
J Hepatol; 2017 Jun; 66(6):1138-1148. PubMed ID: 28189751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]